Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Other Non-Current Assets (2016 - 2025)

Viking Therapeutics (VKTX) has disclosed Other Non-Current Assets for 12 consecutive years, with $46000.0 as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets changed 0.0% to $46000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $46000.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $46000.0 for FY2025, 0.0% changed from the prior year.
  • Other Non-Current Assets hit $46000.0 in Q4 2025 for Viking Therapeutics, roughly flat from $46000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $46000.0 in Q3 2024 to a low of $33000.0 in Q4 2021.
  • Historically, Other Non-Current Assets has averaged $37588.2 across 5 years, with a median of $33000.0 in 2021.
  • Biggest five-year swings in Other Non-Current Assets: changed 0.0% in 2022 and later soared 39.39% in 2024.
  • Year by year, Other Non-Current Assets stood at $33000.0 in 2021, then changed by 0.0% to $33000.0 in 2022, then changed by 0.0% to $33000.0 in 2023, then soared by 39.39% to $46000.0 in 2024, then changed by 0.0% to $46000.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for VKTX at $46000.0 in Q4 2025, $46000.0 in Q3 2025, and $46000.0 in Q2 2025.